Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RATmOzTYudHzJrGPgN6p4gqiRSRXh6Lg-GXhzdIMkF5V8#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "fludarabine phosphate injection is a nucleotide metabolic inhibitor indicated for the treatment of adult patients with b cell chronic lymphocytic leukemia cll who have not responded to or whose disease has progressed during treatment with at least one standard alkylating agent containing regimen benefit in treatment naive or non refractory cll patients is not established 1 1 important limitations fludarabine phosphate should not be used in patients with severe renal impairment creatinine clearance less than 3 ml min 1 73 m 2 5 7 fludarabine phosphate injection is indicated for the treatment of adult patients with b cell chronic lymphocytic leukemia cll who have not responded to or whose disease has progressed during treatment with at least one standard alkylating agent containing regimen the safety and effectiveness of fludarabine phosphate injection in previously untreated or non refractory patients with cll have not been established fludarabine phosphate injection should not be used in patients with severe renal impairment creatinine clearance less than 3 ml min 1 73 m 2 see warnings and precautions 5 7" assertion.
- association object DOID_1040 assertion.
- association predicate treats assertion.
- association subject drugbank:DB01073 assertion.
- association relation TreatmentIndication assertion.
- DOID_1040 category Disease assertion.
- drugbank:DB01073 category Drug assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.